Secret Rebates Erode Drugmaker Revenue, Industry Study Says - Bloomberg

Secret Rebates Erode Drugmaker Revenue, Industry Study Says
Bloomberg
Branded drug companies' share of total U.S. spending on their products is declining, in part because of an increase in secret rebates paid to middlemen, according to an analysis sponsored by an industry group that's been seeking to deflect scrutiny of ...and more »